A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

Clinical trial NCT06887933 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06887933
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2025-04-22
Primary completion: 2026-03-20
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.